2018-10-18T12:27:09-05:00 2017-12-31 521855942 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2017-01-01 231682043 AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS AMER 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 SHARON SWAN CHIEF EXECUTIVE OFFICER 7038366981 2018-10-18 1 R MICHAEL SORRELLS P00001737 2022932200 216.59.105.130 2018-10-18 12:27:07 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 5BC65B47B3A1F1CE2534BD8A8DAEFAC1BF945F16 2017 2018-06-14 16:35:46Z SHARON SWAN 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 4244444 0 X WWW.ASCPT.ORG X 1900 DC ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. 11 11 13 450 1124 -674 99311 60695 3348943 3285136 126592 111004 25022 32514 3599868 3489349 27750 49340 0 0 1321546 1404501 0 0 5180 2391148 2219372 3740444 3673213 -140576 -183864 5268981 5142500 130112 40213 5138869 5102287 X ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. 0 0 1877558 49340 1561503 ANNUAL MEETING: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES. 1159422 1119714 JOURNAL: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS.CPT: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (CPT:PSP) IS AN ONLINE, FULLY OPEN ACCESS JOURNAL. CPT:PSP PROVIDES A UNIQUE INTERNATIONAL FORUM FOR SCIENTISTS IN THE PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY SPACE.CLINICAL AND TRANSLATIONAL SCIENCE (CTS), THE NEWEST JOURNAL OF THE AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, HIGHLIGHTS ORIGINAL TRANSLATIONAL MEDICINE RESEARCH THAT HELPS BRIDGE LABORATORY DISCOVERIES WITH THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASE. NEW CONTENT IS PUBLISHED REGULARLY. 451876 603919 MEMBER SERVICES: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT JOURNAL, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES. 3488856 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 57 0 1 13 1 1 1 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X THE SOCIETY 7038366981 528 NORTH WASHINGTON STREET ALEXANDRIA VA 22314 JULIE A JOHNSON PHARMD PRESIDENT 2.00 X X 0 0 0 DAN HARTMAN PRESIDENT-ELECT 2.00 X X 0 0 0 JILL FIEDLER-KELLY DIRECTOR 2.00 X 0 0 0 WALTER KRAFT MD SECRETARY/TREASURER 2.00 X X 0 0 0 PAOLO VICINI DIRECTOR 2.00 X 0 0 0 MAURICE EMERY PHARMD PHD DIRECTOR 2.00 X 0 0 0 ANNE C HEATHERINGTON PHD DIRECTOR 2.00 X 0 0 0 SEAN HENNESSY PHARMD PHD DIRECTOR 2.00 X 0 0 0 VIRGINIA GINNY D SCHMITH PHD FCP DIRECTOR 2.00 X 0 0 0 DAVID Y MITCHELL PHD DIRECTOR 2.00 X 0 0 0 AUBREY STOCH MD DIRECTOR 2.00 X 0 0 0 SHARON SWAN CHIEF EXECUTIVE OFFICER 40.00 X 371178 0 27932 ELISE LAFFMAN-JOHNSON CHIEF OPERATING OFFICER 40.00 X 167000 0 0 EMMA SHUMEYKO MANAGING EDITOR 40.00 X 105769 0 0 LISA WILLIAMSON SENIOR DIRECTOR OF MEMBER SERVICES 40.00 X 114190 0 6324 758137 0 34256 4 0 1 0 OLD DOMINION RENOVATORS 1665 FRANCIS HAMMOND PARKWAY ALEXANDRIA VA 22302 BUILDING RENOVATIONS 357425 FREEMAN AUDIO VISUAL INC PO BOX 650519 DALLAS TX 752650519 AUDIO VISUAL SERVICES 323320 EUCLID TECHNOLOGY 4500 EAST WEST HIGHWAY 550 BETHESDA MD 20814 TECHNOLOGY SERVICES 114259 3 60695 60695 ANNUAL MEETING REGISTR 900099 1239445 1239445 JOURNALS 900099 1119714 1118590 1124 MEMBERSHIP DUES 900099 603919 603919 EXHIBITS 900099 254558 254558 AM SPONSORSHIPS 900099 67500 67500 3285136 59470 59470 29433 29433 806629 755095 51534 51534 51534 MISCELLANEOUS 900099 3081 3081 3081 3489349 3284012 1124 143518 X 49340 49340 569532 439235 130297 709309 578903 130406 2000 2000 52268 52268 71392 61851 9541 24870 24870 81150 81150 18886 2732 16154 439361 384313 55048 179627 107441 67006 5180 31249 31249 109294 73602 35692 1166127 1135431 30696 792 792 55537 55537 25606 25606 STRATEGIC PLAN & BUSINE 49775 2659 47116 JOURNAL EXPENSES 21783 21783 TAXES 10086 10086 MEMBERSHIP SERVICES + R 5229 3560 1669 628006 -628006 3673213 3488856 179177 5180 254443 201853 888566 670058 0 400 1915115 429778 712154 1485337 2885173 2278082 528645 506770 5268981 5142500 66 0 59396 0 70650 40213 130112 40213 X 4854932 4795380 283937 306907 5138869 5102287 5268981 5142500 -183864 147282 0 X X 1 X 0 0 0 X 98684 46169 30259 99311 60695 335118 2615205 3165820 2790322 3346031 3284012 15201390 2713889 3211989 2820581 3445342 3344707 15536508 0 932521 1226890 916103 956864 1084223 5116601 932521 1226890 916103 956864 1084223 5116601 10419907 91966 102071 108018 92109 88903 483067 91966 102071 108018 92109 88903 483067 7707 3134 10841 1885 12186 3547 6962 3081 27661 2815447 3329380 2932146 3544413 3436691 16058077 0.64890 0.65060 0.03010 0.02900 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INCOME FROM ACTIVITIES NOT NORMALLY RECURRING 3654326 3654326 332716 83179 0 0 287046 311662 336034 332716 1267458 1901187 71762 77916 84009 83179 316866 475299 473937 18545 47693 54895 2732 482548 442881 38541 36173 40810 2848 473937 451852 3628 781 10059 3321 442881 471079 6043 26911 47961 4220 451852 411569 60083 45311 42119 3765 471079 0.36400 0.00000 0.63600 0 0 186000 186000 1449330 282572 1166758 57050 52312 4738 222735 94894 127841 1485337 DUE TO INTERNATIONAL SOCIETY OF PHARMACOMETRICS 40213 40213 X 3617745 147282 147282 3470463 18886 18886 3489349 3654327 0 3654327 18886 18886 3673213 PART V, LINE 4: PURPOSE OF ENDOWMENT: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAMS FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, THE SHEINER-BEAL AWARD, THE GARY NEIL PRIZE, AND THE SCIENTIFIC AWARDS COMMITTEE. PART X, LINE 2: THE SOCIETY HAS EVALUATED ITS TAX POSITIONS FOR ALL OPEN TAX YEARS. CURRENTLY, THE TAX YEARS OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE ARE THE 2015, 2016, AND 2017 TAX YEARS. HOWEVER, THE SOCIETY IS NOT CURRENTLY UNDER AUDIT. BASED ON THE EVALUATION OF THE SOCIETY'S TAX POSITIONS, MANAGEMENT BELIEVES ALL TAX POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISIONS FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAVE BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2017. 1 ASCPT & FDA WILLIAM B. ABRAMS LECTURE 1 1911 GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT 1 2602 SHEINER-BEAL PHARMACOMETRICS AWARD 1 1903 RAWLS-PALMER PROGRESS IN MEDICINE AWARD 1 2346 LEON I. GOLDBERG EARLY INVESTIGATOR AWARD 2 2000 HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD 1 1000 MALLE JURIMA-ROMET MID-CAREER LEADERSHIP AWARD 1 1000 2017 PRESIDENT TRAINEE AWARD 30 15900 2017 PRESIDENT TRAINEE AWARD - TRAVEL STIPEND 19 9500 STATE OF THE ART AWARD 1 1000 PRESIDENT & MORROW AWARD 2 1000 PRESIDENT & MORROW AWARD TRAVEL STIPEND 2 1500 FIRST IN HUMAN HONORARIUM 1 3000 PRESIDENT & GOLDSTIEN AWARD 1 500 PART I, LINE 2: EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. EACH AWARD CANDIDATE IS NOMINATED THROUGH THE SUBMISSION OF A NOMINATION PACKET THAT INCLUDES A SUMMARIZED CV AND COMPREHENSIVE ASSESSMENT OF ALL ASPECTS OF THE CANDIDATES OUTSTANDING ATTRIBUTES. ADDITIONALLY, 1 TO 3 RECOMMENDATIONS MUST BE INCLUDED FROM INDIVIDUALS AS WELL AS THE CANDIDATES COMPLETE CV AND HIGHLIGHTS OF NOTEWORTHY SCIENTIFIC ACCOMPLISHMENTS. AFTER THE SELECTION PROCESS IS COMPLETE, THE RECIPIENTS RECEIVE THE MONETARY AWARD, A TRAVEL STIPEND TO THE ANNUAL MEETING AND RECOGNITION DURING THE ANNUAL MEETING BANQUET. X X X X 0 0 0 0 0 0 0 1 0 SHARON SWAN CHIEF EXECUTIVE OFFICER 370914 0 0 0 264 0 15750 0 14371 0 401299 0 0 0 ELISE LAFFMAN-JOHNSON CHIEF OPERATING OFFICER 166736 0 0 0 264 0 0 0 1232 0 168232 0 0 0 PART I, LINE 7 THE PROCESS FOR CALCULATING THE STAFF BONUS IS DEPENDENT ON PERFORMANCE AND DISCUSSIONS WITH THE COMPENSATION COMMITTEE AND THE CEO. THE CEO'S BONUS IS CALCULATED BASED ON ACHIEVEMENT OF INCENTIVE OBJECTIVES THAT ARE APPROVED BY THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS TWO CLASSES OF MEMBERS: FULL MEMBER AND TRAINEE/STUDENT MEMBER FULL MEMBER: FOR APPLICANTS WHO HAVE EARNED A DOCTORATE DEGREE OR EQUIVALENT IN ANY OF THE BIOMEDICAL SCIENCES. ALSO FOR APPLICANTS IN EXECUTIVE AND LEADERSHIP ROLES IN RELATED ORGANIZATIONS. APPLICANTS MUST DEMONSTRATE A SINCERE INTEREST IN, AND CONTRIBUTIONS TO, HUMAN PHARMACOLOGY AND THERAPEUTICS THROUGH PUBLICATIONS, GRANTS, PATENTS, GOVERNMENTAL REPORTS, COMPANY REPORTS, ETC. TRAINEE/STUDENT MEMBER: FOR APPLICANTS CURRENTLY ENROLLED IN A POST-DOCTORAL TRAINING PROGRAM WHO HAVE DEMONSTRATED AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. ALSO FOR APPLICANTS WHO ARE PURSUING A POST-BACCALAUREATE DEGREE AND WHO POSSESS AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS SHALL HAVE SUCH VOTING PRIVILEGES AS ARE DETERMINED FROM TIME TO TIME BY THE SOCIETY'S GOVERNING BOARD AND SHALL VOTE IN SUCH MANNER AS DETERMINED BY THE GOVERNING BOARD. FORM 990, PART VI, SECTION A, LINE 7B ANY CHANGES TO THE ORGANIZATION'S BYLAWS ARE SUBJECT TO APPROVAL BY THE FULL MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE ASCPT CEO AND ASCPT LEGAL COUNSEL FOLLOWING PREPARATION BY THE SOCIETY'S ACCOUNTANTS. THE OFFICERS OF ASCPT REVIEW THE DOCUMENT PRIOR TO IT BEING FILED. THE BOARD IS INFORMED ABOUT THE PREPARATION AND FILING OF THE FORM 990 AND THE RETURN IS MADE AVAILABLE AT ANY TIME TO ANY BOARD MEMBER FOR HIS OR HER REVIEW. FORM 990, PART VI, SECTION B, LINE 12C ALL ASCPT VOLUNTEER LEADERS COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE. THE CEO, LEGAL COUNSEL, AND SENIOR STAFF ARE AWARE OF CONFLICTS, AND DISCUSS ANY ACTUAL OR POTENTIAL COI ISSUES. CONFLICT OF INTEREST IS DISCUSSED AT THE BEGINNING OF EVERY BOARD OF DIRECTORS CONFERENCE CALL, WITH BOARD MEMBERS BEING ASKED TO DECLARE ANY CONFLICTS AT THE BEGINNING OF THE CALL. FORM 990, PART VI, SECTION B, LINE 15A THE CEO'S COMPENSATION IS DETERMINED BY THE ASCPT COMPENSATION COMMITTEE USING COMPARABILITY DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE CEO USING COMPARABILITY DATA. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE ASCPT WEBSITE. FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 110,243. MANAGEMENT AND GENERAL EXPENSES 54,715. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 164,958. GRAPHIC DESIGN: PROGRAM SERVICE EXPENSES 35,920. MANAGEMENT AND GENERAL EXPENSES 333. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 36,253. JOURNAL HONORARIUM FEES: PROGRAM SERVICE EXPENSES 238,150. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 238,150. FORM 990, PART XII, LINE 1: THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUNTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQUIPMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.